Total Funding
21
46
Total FundingSeries E raised
Growth Score
-3 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
47909
OptiScan Biomedical develops glucose monitoring systems to assist healthcare providers to manage the glucose level of the patients.
Peter R. Rule: CEO
About the Company
OptiScan Biomedical Corporation develops glucose monitoring systems for the intensive care unit (ICU)/CCU. It offers OptiScanner, an automated, bedside glucose monitoring system to assist healthcare providers manage the glucose level of critically ill patients. The company’s OptiScanner provides serial blood glucose measurements for a range of
glucose concentrations. OptiScan Biomedical Corporation was founded in 1994 and is based in Hayward, California.
